Join
Live feed
·
INSIDERFilingvia Quantisnow
Lumos Pharma Inc. logo

SEC Form 4: Karpf David B covered exercise/tax liability with 570 shares, decreasing direct ownership by 7% to 7,330 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
LUMO· Lumos Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LUMO (Lumos Pharma Inc.) and more on Quantisnow.